Organ-specific therapy in critical illness: Interfacing molecular mechanisms with physiological interventions
- 30 June 1996
- journal article
- review article
- Published by Elsevier in Journal of Critical Care
- Vol. 11 (2) , 95-107
- https://doi.org/10.1016/s0883-9441(96)90024-6
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Clinical trials of selective decontamination of the digestive tractCritical Care Medicine, 1990
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasoneClinical Immunology and Immunopathology, 1987
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987
- Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shockCritical Care Medicine, 1985
- The Effects of High-Dose Corticosteroids in Patients with Septic ShockNew England Journal of Medicine, 1984
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Studies of endotoxin-induced decrease in lipoprotein lipase activity.The Journal of Experimental Medicine, 1981